COMPANIES GlaxoSmithKline, the UK-based pharmaceutical group, will cease corporate donations to political parties around the world, in a fresh effort to improve openness and remove accusations of unfair lobbying at a time of likely change to the US healthcare system.
Andrew Witty, the chief executive who took office this spring, told the Financial Times: “I don’t want people to have any question about our involvement in the political process and in ensuring that healthcare is improved.”
